Overview
- An MRI-targeted, image-guided diagnostic pathway reduces unnecessary biopsies and finds clinically significant cancers earlier.
- Many low- and intermediate-risk cancers are now candidates for focal therapy or active surveillance instead of whole-gland treatment.
- Treatment plans balance cancer control with preservation of urinary and sexual function.
Symptoms
- Most early prostate cancers cause no symptoms, detection relies on PSA and imaging.
- Rising PSA over time, or a new abnormal digital rectal exam.
- Less commonly: difficulty urinating, blood in urine or semen, or new bone pain.
How it is diagnosed
- PSA blood test and clinical exam.
- Multiparametric prostate MRI to identify suspicious zones (PI-RADS scoring).
- MRI-fusion targeted biopsy of suspicious areas plus systematic sampling.
- Genomic testing of biopsy tissue when intermediate-risk to guide treatment intensity.
Treatment options
Focal Therapy
Targeted ablation of prostate tumors while preserving healthy tissue and quality of life.
Learn moreRobotic Prostatectomy
The latest robotic technology to remove the prostate with a fast, well-supported recovery.
Learn moreCryotherapy
Image-guided freezing to target cancer cells with precision.
Learn more